Healthline
July 2, 2025
Share on PinterestCompared to BMI scores, body-fat percentages were a stronger predictor of the 15-year mortality risk of young adults, a new study found. Thana Prasongsin/Getty […]
June 30, 2025
Share on PinterestHeart disease overall has decreased by 66% since 1970, but it remains the leading cause of death among Americans. Tashdique Mehtaj Ahmed/Getty Images Heart […]
June 28, 2025
Share on PinterestThimerosal, a mercury-containing preservative, has been in vaccines and other drugs since the 1930s. VioletaStoimenova/Getty Images A CDC advisory panel voted 5–1 to recommend […]
June 26, 2025
Share on PinterestDrinking coffee black without cream or sugar could help reduce your risk of death from cardiovascular disease. Getty Images/Kseniya Ovchinnikova Researchers say daily coffee […]
Medscape
July 3, 2025
The prevalence of irritable bowel syndrome (IBS) and chronic idiopathic constipation among US adults rose significantly during the COVID-19 pandemic, with a near doubling of the […]
July 3, 2025
TOPLINE: Patients with Crohn’s disease who undergo terminal ileum resection have a significantly higher risk of developing colorectal cancer (CRC) and colorectal polyps than those who […]
July 3, 2025
Two studies led by researchers at Imperial College London (ICL) have identified structural brain changes and blood biomarkers linked to dementia in former professional rugby players. […]
July 3, 2025
The FDA has granted accelerated approval to sunvozertinib (Zegfrovy, Dizal Pharmaceutical) for locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor […]
FDA
July 2, 2025
On July 2, 2025, the Food and Drug Administration granted accelerated approval to sunvozertinib (Zegfrovy, Dizal (Jiangsu) Pharmaceutical Co., Ltd.) for adult patients with locally advanced […]
July 2, 2025
AUDIENCE: Patient, Health Care Professional, Pharmacy, Pediatrics ISSUE: The FDA is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD) – including […]
July 2, 2025
On July 2, 2025, the Food and Drug Administration granted accelerated approval to linvoseltamab-gcpt (Lynozyfic, Regeneron Pharmaceuticals, Inc.), a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell […]
July 2, 2025
HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]
